Canadian Activase for Stroke Effectiveness Study "CASES"
Completed
Phase 4 ResultsEligibility Criteria
Inclusion Criteria
Acute ischemic stroke. This study included all patientsgiven intravenous alteplase therapy for acute ischemicstroke in Canada from Feb. 17, 1999, through June 30, 2001.Recruitment
- Study Size: 1,135
- Number of Centers: 60
- Max Time from Onset: 3 Hours
- Follow Up: 3 Days
Principal Investigator
-
Dr. Michael D. Hill
University of Calgary, Canada.
Locations
- Canada